A review of Chlamydia pneumoniae and atherosclerosis

European Journal of Vascular and Endovascular Surgery

Volumn 17, Issue 4, 1999, Pages 283-289

  Fasting, H ^a   Henneberg, E W ^b   Ostergaard L ^c  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b VIBORG HOSPITAL   (Denmark)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZITHROMYCIN; MACROLIDE; PLACEBO; ROXITHROMYCIN;

ABDOMINAL AORTA ANEURYSM; ACUTE HEART INFARCTION; ANTIINFLAMMATORY ACTIVITY; AORTA VALVE; ATHEROSCLEROSIS; BACTERIUM CULTURE; CAROTID ARTERY DISEASE; CHLAMYDIASIS; CHLAMYDOPHILA PNEUMONIAE; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; DISEASE SEVERITY; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PATHOGENICITY; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW; RISK; SERODIAGNOSIS; TREATMENT OUTCOME; VASCULAR SURGERY;

EID: 0033120384     PISSN: 10785884     EISSN: None     Source Type: Journal    
DOI: 10.1053/ejvs.1998.0757     Document Type: Article

References (57)

1. Grayston JT, Campbell LA, Kuo C.C. Chlamydia pneumoniae. Int J Syst Bacteriol. 39:1989;88-90.
2. Juvonen J. Chlamydia pneumoniae. Thesis, University of Oulu, Finland. 1997;1-76.
3. Campbell LA, Kuo CC, Grayston J.T. Structural and antigenic analysis ofChlamydia pneumoniae. Infect Immun. 58:1990;93-97.
4. Schacter J. Pathogenesis of chlamydial infections. Pathol Immunopathol Res. 8:1989;206-220.
5. Saikku P. The epidemiology and significance ofChlamydia pneumoniae. J Infect. 25:1992;27-35.
6. Grayston JT, Wang SP, Yeh LJ, Kuo C.C. Importance of reinfection in the pathogenesis of trachoma. Rev Infect Dis. 7:1985;717-725.
7. Beatty WL, Byrne GI, Morrison R.P. Repeated and persistent infection with Chlamydia and the development of chronic inflammation and disease. Trends Microbiol. 2:1994;94-98.
8. Grayston JT, Campbell LA, Kuo C.C. A new respiratory tract pathogenChlamydia pneumoniae. J Infect Dis. 161:1990;618-625.
9. Odeh M, Oliven A. Chlamydial infections of the heart. Eur J Clin Microbial Infect Dis. 11:1992;885-893.
10. Laurila A, Bloigu A, Nayha S. Chlamydia pneumoniaeHelicobacter pylori. Int J Circumpolar Health. 56:1997;70-75.
11. Karvonen M, Toumilehto J, Pitkaniemi J, Saikku P. The epidemic cycle ofChlamydia pneumoniae. Epid Infect. 110:1993;349-360.
12. Saikku P, Leinonen M, Matilla K. Serological evidence of an association of a novel Chlamydia, TWAR, with chronical coronary heart disease and acute myocardial infarction. Lancet. 2:1988;983-986.
13. Aldous MB, Grayston JT, Wang SP, Foy H.M. Seroepidemiology ofChlamydia pneumoniae. J Infect Dis. 166:1992;646-649.
14. Kuo CC, Jackson LA, Campbell LA, Grayston J.T. Chlamydia pneumoniae. Clin Microbiol Rev. 8:1995;451-461.
15. Østergaard L, Møller JK, Birkelund S, Christiansen G, Anderson P.L. Development of a nested polymerase chain reaction using time resolved fluorometry for automated detection ofChlamydia trachomatis. Immunology & Infectious Diseases. 4:1994;36-40.
16. Thom DH, Grayston JT, Campbell L.A. Respiratory infection withChlamydia pneumoniae. Eur J Clin Microbiol Infect Dis. 13:1994;785-792.
17. Chiu B, Viira E, Tucker W, Fong I.W. Chlamydia pneumoniaeHerpes simplex. Circulation. 96:1997;2144-2148.
18. Kuo CC, Shor A, Campbell L.A. Demonstration ofChlamydia pneumoniae. J Infect Dis. 167:1993;841-849.
19. Maas M, Krause E, Engel PM, Kruger S. Endovascular presence ofChlamydia pneumoniae. Angio. 48:1997;699-706.
20. Nystrom-Rosander C, Thelin S, Hjelm E. High incidence ofChlamydia pneumoniae. Scand J Infect Dis. 29:1997;361-365.
21. Blasi F, Denti F, Erba M. Detection ofChlamydia pneumoniaeHelicobacter pylori. J Clin Microbiol. 34:1996;2766-2769.
22. Saikku P, Leinonen M, Tenkanen L. ChronicChlamydia pneumoniae. Ann Intern Med. 116:1992;273-278.
23. Leinonen M, Linnanmäki E, Matilla K. Circulating immune complexes containing chlamydial lipopolysaccharide in acute myocardial infarction. Microb Pathog. 9:1990;67-73.
24. Thom DH, Wang S, Grayston JT, Siscovick DS, Stewart D.K. Chlamydia pneumoniae. Arterioscler Thromb. 11:1991;547-551.
25. Thom DH, Grayston JT, Siscovick D.S. Asociation of prior infection withChlamydia pneumoniae. JAMA. 268:1992;68-72.
26. Linnanmäki E, Leinonen M, Matilla K. Chlamydia pneumoniae. Circulation. 87:1993;1130-1134.
27. Melnick ST, Shahar E, Folsom A.R. Past infection byChlamydia pneumoniae. Am J Med. 95:1993;499-504.
28. Shor A, Kuo CC, Patton D.L. Detection ofChlamydia pneumoniae. S Aft Med J. 82:1992;158-161.
29. Kuo CC, Grayston JT, Campbell L.A. Chlamydia pneumoniae. Proc Natl Acad Sci USA. 92:1995;6911-6914.
30. Campbell LA, O'Brien ER, Cappuccio A.L. Detection ofChlamydia pneumoniae. J Infect Dis. 172:1995;585-588.
31. Muhlestein JB, Hammond EH, Carlquist J.F. Increased incidence ofChlamydia pneumoniae. J Am Col Cardiol. 27:1996;1555-1561.
32. Grayston JT, Kuo CC, Coulson A.S. Chlamydia pneumoniae. Circulation. 92:1995;3397-3400.
33. Kuo CC, Gown AM, Benditt EP, Grayston J.T. Detection ofChlamydia pneumoniae. Arterioscler Thromb. 13:1993;1501-1504.
34. Ong G, Thomas BJ, Mansfield AO, Davidston BR, Taylor-Robinson D. Detection and widespread distribution ofChlamydia pneumoniae. J Clin Pathol. 49:1996;102-106.
35. Raminez J.A. Isolation ofChlamydia pneumoniae. Ann Intern Med. 125:1996;979-982.
36. Gupta S, Leatham EW, Carrington D. ElevatedChlamydia pneumoniae. Circulation. 96:1997;404-407.
37. Gurfinkel E, Bozovich G, Daroca A, Beck E, Mautner B, for the ROXIS Study Group. Randomised trial of roxithromycin in non-Q-wave coronary syndromes: Roxis pilot study. Lancet. 350:1997;404-407.
38. Godzik KL, O'Brien ER, Wang SK, Kuo C.C. In vitro susceptibility of human vascular wall cells to infection withChlamydia pneumoniae. J Clin Microbiol. 33:1995;2411-2414.
39. Kaukoranta-Tolvanen SS, Laitinen K, Saikku P, Leinonen M. Chlamydia pneumoniae. Microb Pathog. 16:1994;313-319.
40. Fryer RH, Schwobe EP, Woods ML, Rodgers G.M. Chlamydial species infect human vascular endothelial cells and induce procoagulant activity. J Investig Med. 45:1997;168-174.
41. Kalayogly MV, Byrne G.I. Induction of foam cell formation byChlamydia pneumoniae. J Infect Dis. 177:1998;725-729.
42. Laurilla A, Bloigu A, Nayha S. ChronicChlamydia pneumoniae. Arteriosclerosis, Thrombosis & Vascular Biology. 17:1997;2910-2913.
43. Laitinen K, Laurila A, Pyhala L, Leinonen M, Saikku P. Chlamydia pneumoniae. Infect Immun. 65:1997;4832-4835.
44. Muhlestein JB, Anderson JL, Hammond E.H. Infection withChlamydia pneumoniae. Circulation. 97:1998;633-636.
45. Maass M, Gieffers J. Cardiovascular disease risk from priorChlamydia pneumoniae. J Infect. 35:1997;171-176.
46. Puolakkainen M, Kuo CC, Shor A. Serological response toChlamydia pneumoniae. J Clin Pathol. 31:1993;2212-2214.
47. Fong IW, Chiu B, Viira E. Rabbit model forChlamydia pneumoniae. J Clin Microbiol. 35:1997;48-52.
48. Moazed TC, Kuo CC, Grayston JT, Campbell L.A. Murine models ofChlamydia pneumoniae. J Infect Dis. 175:1997;883-890.
49. Whiteman M, Halliwell B. Prevention of peroxynitrite-dependent tyrosine nitration and inactivation of alpha-1-antiprotease by antibiotics. Free Rad Res. 26:1997;49-56.
50. Seppäla H, Klaukka T, Voupio-Varkila J. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in group A streptococci in Finland. N Engl J Med. 337:1997;441-446.
51. Mendall MA, Carrington D, Strahan D. Chlamydia pneumoniae. J Infect. 30:1995;121-128.
52. Weiss SM, Roblin PM, Gaydos C.A. Failure to detectChlamydia pneumoniae. J Infect Dis. 173:1996;957-962.
53. Cook PJ, Honeybourne D, Lip G.Y. Chlamydia pneumoniae. Stroke. 29:1998;404-410.
54. Jackson LA, Campbell LA, Kuo C.C. Isolation ofChlamydia pneumoniae. J Infect Dis. 176:1997;292-295.
55. Kuo CC, Coulson AS, Campbell L.A. Detection ofChlamydia pneumoniae. J Vasc Surg. 26:1997;29-31.
56. Peterson E, Boman J, Persson K. Chlamydia pneumoniae. Eur J Vasc Endovasc Surg. 15:1998;138-142.
57. Lindholt JS, Østergaard L, Henneberg EW, Fasting H, Andersen P.L. Failure to detectChlamydia pneumoniae. Eur J Vasc Endovasc Surg. 15:1998;161-164.